The approval of perpetual futures contracts in the US may lead to unforeseen tax and regulatory challenges for traders if these products are ultimately classified as swaps rather than futures, according to CME Group Chairman and CEO Terry Duffy. This concern stems from the ambiguity surrounding the tax treatment of such contracts, with the IRS yet to provide clear guidance.
Duffy's comments come as CME continues to challenge the Commodity Futures Trading Commission's (CFTC) approval of perpetual futures contracts, with the outcome potentially influencing the US approach to these rapidly growing financial instruments. At the heart of the dispute is whether perpetual futures should be legally treated as futures or swaps, with Duffy arguing that the periodic funding payments exchanged between long and short positions align more closely with the definition of a swap under US law. If perpetual contracts are deemed swaps, they would be subject to 'ordinary' taxation, as opposed to the blended tax treatment available for futures under Section 1256 of the US tax code.
This could result in uncertainty for market participants who have been treating perpetual futures as futures for tax purposes, potentially leading to disputes with the IRS over tax liabilities. Legal experts emphasize that the issue is complex, with the definition of swaps being broad and the economic function of perpetual futures resembling that of traditional futures. The outcome will depend on how the court interprets the law, with the potential for extensive litigation and the need for the IRS to provide separate guidance on tax treatment. Until there is greater clarity, large institutions may face uncertainty over how to report trades involving perpetual futures, highlighting the need for regulatory and tax authorities to address these issues promptly.